• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

槲皮素通过激活 EGFR 过表达口腔癌细胞中的 FOXO1 转录因子诱导细胞生长停滞。

Quercetin induces growth arrest through activation of FOXO1 transcription factor in EGFR-overexpressing oral cancer cells.

机构信息

Department of Nutrition, China Medical University, Taichung, Taiwan, ROC.

出版信息

J Nutr Biochem. 2013 Sep;24(9):1596-603. doi: 10.1016/j.jnutbio.2013.01.010. Epub 2013 Apr 22.

DOI:10.1016/j.jnutbio.2013.01.010
PMID:23618529
Abstract

The squamous cell carcinomas of the head and neck (SCCHNs) with aberrant epidermal growth factor receptor (EGFR) signaling are often associated with poor prognosis and low survival. Therefore, efficient inhibition of the EGFR signaling could intervene with the development of malignancy. Quercetin appears to be antitumorigenesis, but the underlying mechanism remains unclear in oral cancer. Fork-head box O (FOXO) transcription factors, Akt downstream effectors, are important regulators of cell growth. Here, we hypothesized that FOXO1 might be crucial in quercetin-induced growth inhibition in EGFR-overexpressing oral cancer. Quercetin treatment suppressed cell growth by inducing G2 arrest and apoptosis in EGFR-overexpressing HSC-3 and TW206 oral cancer cells. Quercetin inhibited EGFR/Akt activation with a concomitant induction of FOXO1 activation. FOXO1 knockdown attenuated quercetin-induced p21 and FasL expression and subsequent G2 arrest and apoptosis, respectively. Likewise, quercetin suppressed tumor growth in HSC-3 xenograft mice. Taken together, our data indicate that quercetin is an effective anticancer agent and that FOXO1 is crucial in quercetin-induced growth suppression in EGFR-overexpressing oral cancer.

摘要

头颈部鳞状细胞癌(SCCHNs)中存在异常的表皮生长因子受体(EGFR)信号,通常与预后不良和生存率低有关。因此,有效抑制 EGFR 信号可以干预恶性肿瘤的发展。槲皮素似乎具有抗肿瘤作用,但在口腔癌中其潜在机制尚不清楚。叉头框 O(FOXO)转录因子是 Akt 的下游效应物,是细胞生长的重要调节剂。在这里,我们假设 FOXO1 可能在 EGFR 过表达的口腔癌细胞中槲皮素诱导的生长抑制中起关键作用。槲皮素通过诱导 EGFR 过表达的 HSC-3 和 TW206 口腔癌细胞中的 G2 期阻滞和细胞凋亡来抑制细胞生长。槲皮素抑制 EGFR/Akt 的激活,同时诱导 FOXO1 的激活。FOXO1 的敲低减弱了槲皮素诱导的 p21 和 FasL 的表达,以及随后的 G2 期阻滞和细胞凋亡。同样,槲皮素抑制了 HSC-3 异种移植小鼠的肿瘤生长。总之,我们的数据表明,槲皮素是一种有效的抗癌药物,FOXO1 是 EGFR 过表达的口腔癌细胞中槲皮素诱导的生长抑制的关键。

相似文献

1
Quercetin induces growth arrest through activation of FOXO1 transcription factor in EGFR-overexpressing oral cancer cells.槲皮素通过激活 EGFR 过表达口腔癌细胞中的 FOXO1 转录因子诱导细胞生长停滞。
J Nutr Biochem. 2013 Sep;24(9):1596-603. doi: 10.1016/j.jnutbio.2013.01.010. Epub 2013 Apr 22.
2
N-acetylcysteine (NAC) inhibits cell growth by mediating the EGFR/Akt/HMG box-containing protein 1 (HBP1) signaling pathway in invasive oral cancer.N-乙酰半胱氨酸(NAC)通过调节侵袭性口腔癌中的 EGFR/Akt/HMG 框蛋白 1(HBP1)信号通路来抑制细胞生长。
Oral Oncol. 2013 Feb;49(2):129-35. doi: 10.1016/j.oraloncology.2012.08.003. Epub 2012 Sep 1.
3
Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.苯并吡喃衍生物 CDRI-85/287 通过调节雌激素受体 α 和 β 介导的信号,与 EGFR 信号平行,诱导雌激素受体阳性乳腺癌细胞的 G2-M 期阻滞,并抑制肿瘤异种移植物的生长。
Steroids. 2013 Nov;78(11):1071-86. doi: 10.1016/j.steroids.2013.07.004. Epub 2013 Jul 26.
4
Isorhapontigenin induced cell growth inhibition and apoptosis by targeting EGFR-related pathways in prostate cancer.异丹叶大黄素通过靶向前列腺癌中的表皮生长因子受体(EGFR)相关通路诱导细胞生长抑制和凋亡。
J Cell Physiol. 2018 Feb;233(2):1104-1119. doi: 10.1002/jcp.25968. Epub 2017 May 24.
5
Anti-neoplastic activity of low-dose endothelial-monocyte activating polypeptide-II results from defective autophagy and G2/M arrest mediated by PI3K/Akt/FoxO1 axis in human glioblastoma stem cells.低剂量内皮细胞-单核细胞激活肽-II 的抗肿瘤活性源自 PI3K/Akt/FoxO1 轴介导的人类神经胶质瘤干细胞自噬缺陷和 G2/M 期阻滞。
Biochem Pharmacol. 2014 Jun 15;89(4):477-89. doi: 10.1016/j.bcp.2014.04.014. Epub 2014 Apr 30.
6
Curcumin inhibits oral squamous cell carcinoma proliferation and invasion via EGFR signaling pathways.姜黄素通过表皮生长因子受体(EGFR)信号通路抑制口腔鳞状细胞癌的增殖和侵袭。
Int J Clin Exp Pathol. 2014 Sep 15;7(10):6438-46. eCollection 2014.
7
Curcumin induces G2/M arrest and triggers apoptosis via FoxO1 signaling in U87 human glioma cells.姜黄素通过FoxO1信号通路诱导U87人胶质瘤细胞发生G2/M期阻滞并引发凋亡。
Mol Med Rep. 2016 May;13(5):3763-70. doi: 10.3892/mmr.2016.5037. Epub 2016 Mar 21.
8
Akt-FOXO3a signaling axis dysregulation in human oral squamous cell carcinoma and potent efficacy of FOXO3a-targeted gene therapy.Akt-FOXO3a 信号轴失调与人类口腔鳞状细胞癌及靶向 FOXO3a 的基因治疗的显著疗效
Oral Oncol. 2011 Jan;47(1):16-21. doi: 10.1016/j.oraloncology.2010.10.010. Epub 2010 Nov 24.
9
T63, a new 4-arylidene curcumin analogue, induces cell cycle arrest and apoptosis through activation of the reactive oxygen species-FOXO3a pathway in lung cancer cells.T63,一种新型的 4-芳基姜黄素类似物,通过激活肺癌细胞中的活性氧-FOXO3a 通路诱导细胞周期停滞和细胞凋亡。
Free Radic Biol Med. 2012 Dec 15;53(12):2204-17. doi: 10.1016/j.freeradbiomed.2012.10.537. Epub 2012 Oct 17.
10
Transcription factor HBP1 is a direct anti-cancer target of transcription factor FOXO1 in invasive oral cancer.转录因子HBP1是侵袭性口腔癌中转录因子FOXO1的直接抗癌靶点。
Oncotarget. 2017 Feb 28;8(9):14537-14548. doi: 10.18632/oncotarget.14653.

引用本文的文献

1
Therapeutic effects of quercetin in oral cancer therapy: a systematic review of preclinical evidence focused on oxidative damage, apoptosis and anti-metastasis.槲皮素在口腔癌治疗中的治疗效果:一项针对氧化损伤、细胞凋亡和抗转移的临床前证据的系统综述
Cancer Cell Int. 2025 Feb 24;25(1):66. doi: 10.1186/s12935-025-03694-1.
2
Targeting Mitochondrial Dysfunction for the Prevention and Treatment of Metabolic Disease by Bioactive Food Components.通过生物活性食品成分靶向线粒体功能障碍以预防和治疗代谢性疾病
J Lipid Atheroscler. 2024 Sep;13(3):306-327. doi: 10.12997/jla.2024.13.3.306. Epub 2024 Jun 17.
3
An Integrated Approach of Network Pharmacology, Bioinformatics, Molecular Docking, and Experimental Verification Uncovers as the Potential Medicine of Prognosis Improvement for Oral Squamous Cell Carcinoma.
网络药理学、生物信息学、分子对接和实验验证的综合方法揭示了其作为改善口腔鳞状细胞癌预后的潜在药物。
Curr Pharm Des. 2025;31(5):391-412. doi: 10.2174/0113816128328547240827045955.
4
An extensive analysis of the prognostic and immune role of FOXO1 in various types of cancer.对 FOXO1 在多种癌症中的预后和免疫作用进行了广泛分析。
Braz J Med Biol Res. 2024 May 3;57:e13378. doi: 10.1590/1414-431X2024e13378. eCollection 2024.
5
Quercetin Induces Cell Cycle Arrest and Apoptosis in YD10B and YD38 Oral Squamous Cell Carcinoma Cells.槲皮素诱导 YD10B 和 YD38 口腔鳞状细胞癌细胞的细胞周期停滞和凋亡。
Asian Pac J Cancer Prev. 2023 Jan 1;24(1):283-289. doi: 10.31557/APJCP.2023.24.1.283.
6
Oral Squamous Cell Carcinoma Cells with Acquired Resistance to Erlotinib Are Sensitive to Anti-Cancer Effect of Quercetin via Pyruvate Kinase M2 (PKM2).获得厄洛替尼耐药性的口腔鳞状细胞癌细胞对槲皮素通过丙酮酸激酶 M2(PKM2)的抗癌作用敏感。
Cells. 2023 Jan 1;12(1):179. doi: 10.3390/cells12010179.
7
Molecular pathways modulated by phytochemicals in head and neck cancer.植物化学物质在头颈癌中调节的分子途径。
J Cell Commun Signal. 2023 Sep;17(3):469-483. doi: 10.1007/s12079-022-00711-0. Epub 2022 Dec 1.
8
Multi-omics analysis to screen potential therapeutic biomarkers for anti-cancer compounds.多组学分析以筛选抗癌化合物的潜在治疗生物标志物。
Heliyon. 2022 Jul 13;8(9):e09616. doi: 10.1016/j.heliyon.2022.e09616. eCollection 2022 Sep.
9
Halogenated Flavonoid Derivatives Display Antiangiogenic Activity.卤代黄酮衍生物具有抗血管生成活性。
Molecules. 2022 Jul 25;27(15):4757. doi: 10.3390/molecules27154757.
10
Application of Quercetin in the Treatment of Gastrointestinal Cancers.槲皮素在胃肠道癌症治疗中的应用。
Front Pharmacol. 2022 Apr 6;13:860209. doi: 10.3389/fphar.2022.860209. eCollection 2022.